PharmaTher Holdings Ratios and Metrics

Market cap in millions CAD. Fiscal year is June - May.

Millions CAD. Fiscal year is Jun - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Mar '26 Mar 9, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021	2020
Market Capitalization	8	19	19	10	13	20	Upgrade
Market Cap Growth	-56.30%	-2.33%	96.23%	-26.13%	-32.76%	-	Upgrade
Enterprise Value	7	17	16	2	1	12	Upgrade
Last Close Price	0.09	0.21	0.21	0.11	0.15	0.28	Upgrade
PE Ratio	-	-	-	-	-	7.33	Upgrade
PB Ratio	14.44	19.09	8.14	1.79	1.11	3.50	Upgrade
P/TBV Ratio	14.44	19.09	8.14	1.79	1.11	3.50	Upgrade
P/FCF Ratio	-	-	-	-	-	21.27	Upgrade
P/OCF Ratio	-	-	-	-	-	21.17	Upgrade
EV/FCF Ratio	-	-	-	-	-	13.60	Upgrade
Net Debt / Equity Ratio	-1.44	-1.15	-0.98	-1.15	-1.02	-1.05	Upgrade
Net Debt / EBITDA Ratio	-	0.74	0.76	1.58	3.06	2.42	Upgrade
Net Debt / FCF Ratio	0.75	0.93	0.65	1.93	3.45	-6.40	Upgrade
Quick Ratio	1.77	3.11	9.19	7.07	36.79	33.65	Upgrade
Current Ratio	1.77	3.11	9.25	7.07	36.82	33.84	Upgrade
Return on Equity (ROE)	-137.97%	-92.20%	-80.35%	-74.39%	-46.06%	89.36%	Upgrade
Return on Assets (ROA)	-62.63%	-48.47%	-42.76%	-26.79%	-27.35%	-47.95%	Upgrade
Return on Capital Employed (ROCE)	-261.00%	-156.50%	-130.30%	-73.10%	-33.50%	-42.10%	Upgrade
Earnings Yield	-18.95%	-8.21%	-16.37%	-66.16%	-30.55%	13.64%	Upgrade
FCF Yield	-	-6.51%	-18.50%	-33.36%	-26.74%	4.70%	Upgrade
Buyback Yield / Dilution	-1.49%	-0.33%	-0.07%	-8.71%	-10.70%	-114.98%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.